$PXYN DD on my OTC Pick for this week's contest: - OTCQB

$PXYN DD on my OTC Pick for this week's contest:

- OTCQB SEC Filer
- Reported $23M on audited Form 10Q for Q2 2014
- Pharmaceutical Company Buyout Candidate
- Cash Flow Positive in Q3 from creative in house factoring
- Projected Revenue of $200M over next 12 months
- 75M share float
- Strong Marketing/Awareness to now start for new Name and Symbol


PXYN Two Press Releases from last week

Praxsyn Now Licensed to Dispense Medication in Twelve States

Praxsyn Corporation Sep 4, 2014 3:25 PM

GlobeNewswire
IRVINE, Calif., Sept. 4, 2014 (GLOBE NEWSWIRE) -- Praxsyn Corporation (PAWS), today announced that its subsidiary, Mesa Pharmacy Inc., a medication and service provider for medical practitioners, is making progress towards its goal of dispensing its customized medications nationwide. The company is now licensed to dispense its medications in the following twelve states:

Arizona
California
Florida
Hawaii
Illinois
Indiana
Nevada
New Mexico
Oklahoma
Texas
Washington
Wisconsin

Praxsyn is headquartered in Southern California at 18011 Sky Park Circle, Suite N, Irvine, CA 92614, and can be contacted directly at (949) 777-6112.

About Praxsyn

At Praxsyn, we work to realize the vision of medical professionals to improve the lives of patients. Mesa Pharmacy, our wholly owned subsidiary, provides doctors with an alternative to oral pain medications. Mesa focuses on providing custom compounded non-narcotic, transdermal topical pain medications that are marketed to industrial health physicians and medical clinics. Mesa has developed a series of topical creams, in different strengths, that provide the pain relief doctors seek for their patients. Additional company information can be found at www.praxsyn.com.


Contact:
Media/Investor Contact:
IR@PraXsyn.com
949-777-6112 ext 101


Praxsyn Announces Official Name Change and New Trading Symbol PXYN

Praxsyn Corporation Sep 5, 2014 3:53 PM

GlobeNewswire
IRVINE, Calif., Sept. 5, 2014 (GLOBE NEWSWIRE) -- Praxsyn Corporation (OTCQB : PXYN), a medication and service provider for medical practitioners, announced that it has received approval from the Financial Industry Regulatory Authority ("FINRA" for an official change in the name of the Company effective at the open of business on September 5, 2014. As previously announced, the Company changed its name to Praxsyn Corporation and will now trade under the symbol "PXYN".

"The name has been changed to reflect the Company's current business of pharmaceutical services, and is no longer affiliated with pet services," said Edward F. Kurtz, Chief Operating Officer, Praxsyn Corporation.

About Praxsyn

At Praxsyn, headquartered in Irvine, California, we work to realize the vision of medical professionals to improve the lives of patients. Mesa Pharmacy, our wholly owned subsidiary, provides doctors with an alternative to oral pain medications. Mesa focuses on providing custom compounded non-narcotic, transdermal topical pain medications that are marketed to industrial health physicians and medical clinics. Mesa has developed a series of topical creams, in different strengths, that provide the pain relief doctors seek for their patients. Additional company information can be found at www.praxsyn.com.


Contact:
Media/Investor Contact:
IR@PraXsyn.com
949-777-6112 ext 101